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after TAAA surgery was 16% in a large series of
patients.1 This complication is the result of a temporary
or definitive interruption of spinal cord blood supply.
Despite numerous spinal cord protective strategies, a
lower extremity neurologic deficit after TAAA surgery
remains a distinct possibility.2-6
Preconditioning the brain with a nonlethal period of
ischemia (insufficient to produce irreversible neuronal
damage) has consistently been shown to induce toler-
ance to a subsequent otherwise lethal ischemic insult 1
to 7 days after the ischemic pretreatment.7,8 Although
the exact mechanism of the neuroprotective effect of
ischemic pretreatment is not fully understood, the acqui-
sition of ischemic tolerance has been related to a repro-
gramming of gene expression.9,10 In particular, the
induction of heat shock protein (HSP) 72 is thought to
be involved.8 It would be advantageous if spinal cord
neurons also possessed an inducible endogenous mech-
anism that increases ischemic tolerance similar to that
observed in cerebral neuronal tissue. Ideally, this toler-
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Objective: In the present study, we investigated the effect of ischemic pre-
treatment on heat shock protein 72 concentration and neurologic and
histopathologic outcome after transient spinal cord ischemia.
Methods: In 28 New Zealand White rabbits, an aortic occlusion device was
placed infrarenally. The animals were randomly assigned to 2 groups:
ischemic pretreatment (n = 14 animals) and control (n = 14 animals). The
duration of ischemic pretreatment was 6 minutes. After 24 hours, the aorta
was occluded for 26 minutes in both groups of animals. Neurologic function
was assessed 24 and 48 hours after the definite ischemic insult. At 48 hours,
the animals were killed for histopathologic evaluation of the spinal cord. In
a separate set of animals, heat shock protein 72 levels were determined in the
lumbar spinal cord after both a 6- and 10-minute ischemic period, with the
use of a Western blot analysis.
Results: No significant difference in neurologic outcome between the groups
was observed at 24 and 48 hours. The incidence of paraplegia and severe
paresis at 48 hours was 79% in the control group and 92% in the ischemic
pretreatment group. There was no difference in histopathologic scores
between the groups. Heat shock protein 72 could be clearly detected 1 and 2
days after 6- or 10-minute periods of spinal cord ischemia.
Conclusions: In the present rabbit study, ischemic pretreatment could not
induce tolerance against a moderately severe spinal cord ischemic insult,
despite increased heat shock protein 72 levels after the preconditioning stim-
ulus. (J Thorac Cardiovasc Surg 2000;120:513-9)
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ance could then be activated pharmacologically before
an anticipated ischemic event. In other models of
ischemia, pharmacologic induction of ischemic toler-
ance has been described. For example, in vitro chemical
preconditioning enhanced functional recovery in hip-
pocampal slices after ischemia,11 and in a model of
myocardial ischemia, the antibiotic herbimycin-A could
induce the genetic expression of HSPs and ischemic tol-
erance.12 One recent experiment demonstrated that
ischemic pretreatment protected the spinal cord against
a mild ischemic insult.13 When ischemic precondition-
ing would induce tolerance against a relatively severe
ischemic spinal cord insult (ie, likely to result in para-
plegia or severe paresis), the induction of tolerance
indeed might allow a new therapeutic approach to min-
imize the neuronal injury that results from transient
spinal cord ischemia during operations for TAAA. 
The present study was designed to assess the effect of
ischemic pretreatment on neurologic and histopatho-
logic outcome in a rabbit model of moderately severe
transient spinal cord ischemia. In addition, spinal HSP
72 levels were determined after sublethal “precondi-
tioning” ischemic periods.
Methods
Animal care and all procedures were performed in compli-
ance with The National Guidelines for Care of Laboratory
Animals in The Netherlands. The study protocol was
approved by the Animal Research Committee of the
Academic Hospital at the University of Amsterdam, The
Netherlands. Twenty-eight New Zealand White rabbits,
weighing 3.0 to 3.5 kg, were randomly assigned to 1 of 2
groups: group I, transient spinal cord ischemia (26 minutes)
without ischemic pretreatment (n = 14 control animals);
group II, transient spinal cord ischemia 24 hours after 6 min-
utes of ischemic pretreatment (n = 14 animals). HSP 72 pro-
duction was assessed in the lumbar spinal cord after sublethal
“preconditioning” periods of ischemia in an additional group
of animals (n = 8 animals). To accustom the rabbits to the
awake part of the experiment, we domesticated all animals by
taking them out of their cages and placing them on the oper-
ating table twice daily, starting 7 days before the experiment.
Operative procedure. After being premedicated with keta-
mine 25 mg/kg and xylazine 5 mg/kg intramuscularly, the ani-
mals were anesthetized with 1.0% halothane in a mixture of
50% oxygen in nitrous oxide by mask. An intravenous catheter
(20-gauge) was placed in an ear vein. Normal saline solution
was infused at a rate of 4 mL/kg per hour. The animals were
allowed to breathe spontaneously. Intravenous cephalothin (25
mg/kg) was administered before the incision was made. During
the procedure, the heart rate was recorded from the electrocar-
diograph, and the blood pressure was recorded continuously
with a noninvasive blood pressure monitor (Finapress; Datex-
Ohmeda Division, Instrumentarium Corp, Helsinki, Finland).
Fur was clipped from the left flank. After preparation of the
skin with iodine and infiltration with bupivacaine 0.5% (1 mL),
a horizontal flank incision was made, and the infrarenal aorta
was exposed through a retroperitoneal approach. An aortic
occlusion device (Uno, Zevenaar, The Netherlands), consisting
of a 2F polyethylene snare in a 10.5F dual-lumen catheter, was
carefully placed around the aorta immediately distal to the
renal arteries. The catheter and the snare were tunneled into a
subcutaneous pouch on the anterolateral abdomen. The wound
was closed in layers, and anesthesia was discontinued.
Ischemic pretreatment. Twenty-four hours after the
placement of the snare, the rabbits of groups I and II were
placed on the operating table (nonanesthetized), and the non-
invasive continuous blood pressure monitor was placed
around the left hind leg. The wound was infiltrated with
bupivacaine 0.25% (2 mL). One or 2 stitches of the operative
wound were opened, and the snare tubing was retrieved. In
group II, the aorta was occluded for 6 minutes by a tighten-
ing of the snare through the dual-lumen catheter. Definitive
occlusion was confirmed by the loss of pulsatile pressure on
the continuous blood pressure monitor. Reperfusion was ver-
ified by the reappearance of the pulsatile pressure waveform.
Thereafter, the wound was closed, and all animals were
placed back in their cages.
Spinal cord ischemia. Twenty-four hours after ischemic
pretreatment, the animals of groups I and II were placed on
the operating table, and the continuous blood pressure moni-
tor was placed around the left hind leg. The wound was infil-
trated with 2 mL of 0.25% bupivacaine, and the same stitch-
es were reopened to retrieve the snare tubing. The aorta was
occluded for 26 minutes in all animals while they were
awake. Rectal temperature was recorded continuously before,
during, and after the ischemic period. Pressure distal to the
occlusion device was recorded continuously before, during,
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Fig 1.  Boxplot of the Tarlov scores of each group of animals
at 48 hours. The Tarlov score is on a 5-point scale: 0 (com-
plete paraplegia with no lower-extremity motor function) to 4
(normal motor function). Horizontal bars represent the 90th,
75th, 50th (median), 25th, and 10th percentiles.
and for 15 minutes after the occlusion period. Aortic occlu-
sion and reperfusion were confirmed by the loss and reap-
pearance of pulsatile blood pressure.
Neurologic scoring system. The animals were neurologi-
cally scored on a 5-point scale (modified Tarlov score) 24
hours after the ischemic pretreatment and 24 and 48 hours
after the definite ischemic insult by a blinded observer: 0,
paraplegia with no lower-extremity motor function; 1, poor
lower-extremity motor function (flicker of movement or
weak antigravity movement only); 2, some lower-extremity
motor function with good antigravity strength but an inabili-
ty to draw legs under body and/or hop; 3, the ability to draw
legs under body and hop but not normally; 4, normal motor
function. Depending on the severity of the neurologic dys-
function, bladder contents were expressed twice daily with
the Credé maneuver.
Spinal cord histopathologic features. Two days after the
definite ischemic insult, the animals were anesthetized with
1% halothane by mask after premedication with ketamine 25
mg/kg and xylazine 5 mg/kg intramuscularly. The animals
were given 2500 U of heparin and were killed with 100 mg
of pentobarbital. Subsequently, the animals were perfusion
fixated with 3.6% formalin after being flushed with normal
saline solution. The lumbosacral portion of the spinal cord
was taken out en bloc, and the spinal cord was carefully
removed. Formalin was used as a fixative for at least 10 days.
The L2 to L5 segments were dissected in 12 pieces. A 1-
mm block of tissue was taken from each piece. The blocks
were embedded in paraffin, and 4-mm thick sections were
stained with hematoxylin and eosin. One section from each
block was evaluated by an experienced histopathologist (I.V.)
who was unaware of the experimental conditions.
Histopathologic changes of the gray matter were scored on a
7-point scale: 0, no lesion observed; 1, gray matter contained
1 to 5 eosinophilic neurons; 2, gray matter contained 5 to 10
eosinophilic neurons; 3, gray matter contained more than 10
eosinophilic neurons; 4, small infarction (less than one third
of the gray matter area); 5, moderate infarction (one third to
one half of the gray matter area); and 6, large infarction (more
than one half of the gray matter area). The scores from all the
sections from each spinal cord were averaged to give a final
score for an individual animal.
Western blot analysis of spinal cord HSP 72 content. The
production of HSP 72 in the lower lumbar portion of the
spinal cord was assessed after sublethal “preconditioning”
ischemic periods in 7 animals. The snare to produce spinal
cord ischemia was applied as described earlier. After 24 hours,
the animals were placed on the operating table (in the awake
state), and the aorta was occluded. Aortic occlusion and reper-
fusion was confirmed by the loss and reappearance of pul-
satile blood pressure with the noninvasive continuous blood
pressure monitor. In 5 animals, the aorta was occluded for 6
minutes. HSP 72 content was determined after 24 hours (n =
3 animals) and after 48 hours (n = 2 animals). In 2 animals, the
aorta was occluded for 10 minutes, and the HSP 72 content
was determined after 48 hours. So that spinal cord tissue could
be obtained at the L4 to L5 level, the animals were killed with
300 mg sodium pentobarbital (Nembutal), and the cord was
quickly harvested with the plunger of a 1-mL syringe and
immediately frozen in liquid nitrogen. HSP 72 content was
semiquantitatively determined with a Western blot analysis,
with chemoluminescence. One normal spinal cord was used to
measure baseline chemoluminescence. The spinal cord sam-
ples were lysed with an UltraTurrax homogenizer (Jahnke und
Kinkel, Staufen, Germany). The lysate was centrifuged
(15,000g for 10 minutes), and the supernatant was frozen
(–70°C). Lysate (10 µL) was mixed with 10 µL loading buffer
(protein concentration, 60 mg/mL) and was applied to a stan-
dard 10% sodium dodecylsulfate–polyacrilamide gel elec-
trophoresis and electroblotted onto a polyvinylidenedifluoride
membrane. The blot was blocked with 5% casein-hydrolysate
(Boehringer Mannheim, Germany) in phosphate-buffered
saline solution (PBS). The first antibody (anti-HSP 72, MA 3-
007; Affinity BioReagents, Inc, Golden, Colo) was diluted
1:1000 in 5% casein/PBS and incubated for 1 hour at 30°C.
The gel was washed (3 × 10 minutes) with PBS/0.05% NP 40.
Thereafter the second antibody (goat-anti mouse peroxidase-
conjugated, Boehringer Mannheim) was administered (diluted
1:1000 in 5% casein/PBS) and incubated for 1 hour at 30°C.
The gel was washed (3 × 10 minutes), and the chemolumis-
cent peroxidase substrate (LumiLightplus; Boehringer
Mannheim) was added for 5 minutes. Thereafter, quantifica-
tion and detection was performed with the Lumi-Imager
device (Boehringer Mannheim). Recombinant pure HSP 72
(StressGen, Biotechnologies Corp, Vancouver, British
Columbia, Canada) was used as positive control (200 ng).
Statistical analysis. The duration of aortic occlusion was
chosen to produce 80% paraplegia and severe paresis (Tarlov
score, 0, 1, 2) in the control group. Awake aortic occlusion of
26 minutes was observed in several studies to produce the
required rate and severity of neurologic deficits.14,15 A sample
size of 14 animals in each group was necessary to acquire suf-
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Fig 2.  Boxplot of the histopathologic scores of each group of
animals. Histopathologic score is on a 7-point scale: 0 (nor-
mal) to 6 (severe gray matter necrosis). Horizontal bars rep-
resent the 90th, 75th, 50th (median), 25th, and 10th per-
centiles.
ficient power (1-β, 0.80; α, 0.05) to demonstrate a decrease in
the incidence of paraplegia and severe paresis from 0.8 in con-
trol animals to 0.3 in the preconditioning group.
Physiologic data are expressed as means ± SD. Blood pres-
sures distal to the occlusion device were averaged before,
during, and 15 minutes after aortic occlusion. Neurologic out-
come and histopathologic scores are expressed as medians
and 10th to 90th percentiles. The Mann-Whitney U test was
used to compare the histopathologic score, the neurologic
score (Tarlov), and physiologic data. The Fisher exact test
was used for the comparison of the overall incidence of neu-
rologic deficits, the incidence of paraplegia, the incidence of
paraparesis, and the incidence of paraplegia and severe para-
paresis.
Results
Distal pressures before aortic occlusion were 88 ± 14
mm Hg and 84 ± 9 mm Hg in the control and ischemic
pretreatment groups, respectively (P = .49). During
occlusion, pressures were 8 ± 4 mm Hg and 10 ± 3 mm
Hg (P = .08). After the occlusion, blood pressures
returned to 85 ± 14 mm Hg and 77 ± 15 mm Hg, respec-
tively (P = .15). Temperatures were 39.0°C ± 0.5°C and
39.3°C ± 0.5°C at the start of aortic occlusion in the con-
trol and ischemic pretreatment groups, respectively 
(P = .22). During occlusion, temperatures slightly
decreased to 38.8°C ± 0.5°C in the control group and
38.9°C ± 0.5°C in the ischemic pretreatment group 
(P = .57). After 15 minutes of reperfusion, temperatures
were 38.9°C ± 0.4°C in the control group and 38.9°C ±
0.4°C in the ischemic pretreatment group (P = .87).
Neurologic outcome. The Tarlov scores are provided
as a boxplot in Fig 1. Overall neurologic outcomes are
shown in Table I. After 24 and 48 hours, no significant
difference in neurologic outcome between the groups
was observed. After 24 hours, the Tarlov scores were 1
(0-3) and 0.5 (0-2.1); after 48 hours, the scores were
1.5 (0-3) and 1 (0-2.1) in the control and ischemic pre-
treatment groups, respectively. Eleven of 14 animals
(79%) in the control group and 13 of 14 animals (92%)
in the pretreatment group had paraplegia or severe
paresis at 48 hours. Ten animals in both groups
required expression of bladder contents.
Histopathologic scores. Histopathologic scores in
the control and ischemic pretreatment groups were 3.6
(2.8-5.5) and 4.1 (3.2-5.3), respectively (P = .31; Fig
2). In general, either minimal damage involving a few
necrotic neurons or infarctions were detected. In most
animals, the infarctions were found in the lower lumbar
segments only, but in some animals the whole lumbar
spinal cord was severely damaged. Selective neuronal
necrosis was rarely seen, but in 1 animal numerous
eosinophilic neurons were found in all segments. In 3
animals (2 control and 1 ischemic pretreatment), the
spinal cord was not adequately perfusion fixated, and
the spinal cords could not be evaluated.
HSP 72.  Neurologic deficits were not observed in
the animals in which HSP 72 was determined after 6 or
10 minutes of spinal cord ischemia. The chemolumi-
nescent data demonstrated that the HSP 72 content was
elevated in the lower lumbar spinal cords of all 7 ani-
mals that were subjected to sublethal durations of
spinal cord ischemia (Fig 3). The relative HSP 72
increase, as compared with the nonischemic control
spinal cord sample, was highest in the 3 animals that
were killed 24 hours after 6 minutes of spinal cord
ischemia (370%, 240%, and 230%), whereas the rela-
tive HSP 72 increase 48 hours after 6 minutes of spinal
cord ischemia was 180% and 160%. In the 2 animals
that were subjected to 10 minutes of spinal cord
ischemia, the relative HSP 72 increase after 48 hours
was 170% and 160% (Fig 4).
Discussion
In the present rabbit study, 6 minutes of ischemic
pretreatment 24 hours before a moderately severe
spinal cord ischemic insult could not improve neuro-
logic and histopathologic outcome. In a separate set
of animals, a similar ischemic period (as that used for
the preconditioning) clearly increased HSP 72 con-
centration.
Infrarenal aortic occlusion in the rabbit is a repro-
ducible model to produce transient spinal cord
ischemia. The duration of ischemia correlates with
histopathologic injury and with the degree of function-
al impairment.16 In the present study, the placement of
an aortic occlusion device permitted repeated awake
occlusions of the aorta, which we could confirm with a
noninvasive continuous blood pressure monitor.
The acquisition of ischemic tolerance by ischemic
pretreatment has been related to the induction of HSPs.
The HSPs prevent the disruption of proteins and bind to
abnormal proteins until they are refolded or disinte-
grated. The expression pattern of HSP, especially the
72-kDa HSP, in ischemic preconditioning was de-
scribed to be compatible with the dose response and
time window of ischemic tolerance.17 In the present
study, HSP 72 was measured to validate the experi-
mental model (ie, to assess whether the 6 minutes of
ischemic pretreatment was sufficiently severe to result
in HSP 72 production). HSP 72 was determined after 2
durations of ischemic pretreatment and 2 time windows
between pretreatment and definite insult to confirm that
the global pattern of HSP 72 expression was in agree-
ment with the present literature.
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The protection provided by ischemic preconditioning
is dependent on the duration of ischemic pretreatment,
the time window between pretreatment and subsequent
insult, and the severity of the subsequent ischemic
insult. These variables allow numerous combinations.
Therefore, the lack of neuroprotection by ischemic pre-
conditioning in the present study might be explained
both by a too long or too short duration of ischemic
pretreatment. Indeed, the duration of the precondition-
ing stimulus might have been too long, as suggested by
the increased incidence of severe neurologic deficits in
the ischemic pretreatment group (92% vs 79%) at 48
hours. However, this is unlikely because a relatively
long period of ischemic pretreatment (10 minutes) was
found to be neuroprotective in a similar model of mild
spinal cord ischemia (15-minute duration).13 These
longer periods of ischemic pretreatment carry the risk
of producing irreversible damage by themselves.
Drummond and Moore18 described that the awake
duration of spinal cord ischemia that had a 50% chance
to produce neurologic deficits was approximately 12
minutes in unanesthetized rabbits. By way of avoiding
the possible induction of irreversible damage, the dura-
tion of ischemic pretreatment should be considerably
shorter. The duration of ischemic pretreatment in the
present study (6 minutes) might have been too short to
induce tolerance. However, this seems improbable
because the acquisition of ischemic tolerance with
ischemic preconditioning is thought to be mediated by
HSP 72.17 In the present experiment, HSP 72 was
clearly increased after 2 sublethal ischemic periods,
with HSP 72 content being maximal 24 hours after a 6-
minute period of spinal cord ischemia. In addition, a
recent rabbit study showed that 5 minutes of ischemic
preconditioning could enhance the tolerance of the
spinal cord to ischemia.19
For several reasons, we opted to investigate the effect
of ischemic pretreatment after an interval of 24 hours.
HSP 72, which is thought to be important for the acqui-
sition of neuroprotection with ischemic precondition-
ing, was mainly produced in the rabbit spinal cord
between 8 and 24 hours after the ischemic pretreat-
ment, whereas HSP 72 levels were lower at 48 hours.13
This trend of expression was confirmed in the present
study. In models of cerebral ischemia, a 24-hour inter-
val between ischemic pretreatment and the subsequent
ischemic insult resulted in ischemic tolerance.7,8,20 In
addition, occlusion of several segmental arteries in the
rabbit resulted in tolerance to a spinal cord ischemic
insult within a 24-hour interval.21 The protection
achieved with this method was attributed to ischemic
preconditioning.
In a model of temporary spinal cord ischemia in the
Japanese White rabbit, 15 minutes of ischemia 2 days
after 10 minutes of ischemic pretreatment improved
functional and histopathologic outcome.13 In that
study, the ischemic insult produced only mild neuro-
logic deficits in the control group (Tarlov scores 0 and
1 were not observed). Therefore, the most likely expla-
nation for the lack of protection by ischemic pretreat-
ment in the present study is that the duration of the sec-
ond ischemic insult was too long. However, our study
was designed to evaluate whether ischemic pretreat-
ment might protect against a clinically relevant (mod-
erately severe) ischemic insult, which would result in a
substantial rate of paraplegia or severe paraparesis.
During TAAA surgery, the induction of ischemic toler-
ance by pharmacologic agents or other means can be
clinically valuable if tolerance could be induced
against a moderately severe ischemic insult. In this
respect, it is important to point out that, after TAAA
surgery, a mild paraparesis is likely to resolve and that
most of these patients are able to regain their preopera-
tive level of functioning.1 Instead, paraplegia or severe
paraparesis is the most challenging problem, because
severe deficits result in permanent disablement and are
The Journal of Thoracic and
Cardiovascular Surgery
Volume 120, Number 3
de Haan et al 517
Table I.  Neurologic outcomes after temporary spinal cord ischemia (26 minutes) in the control (n = 14 animals)
and ischemic pretreatment (n = 14 animals) group at 48 hours
Control Ischemic pretreatment P value
Tarlov score* (range) 1.5 (0-3) 1 (0-2.1) .12
Overall incidence of neurologic deficits† (%) 14/14 (100) 14/14 (100) >.99
Incidence of complete paraplegia‡ (%) 3/14 (21) 6/14 (43) .42
Incidence of paraparesis§ (%) 11/14 (79) 8/14 (57) .42
Incidence of paraplegia and severe paraparesis (%) 11/14 (79) 13/14 (92) .60
*The Tarlov score is on a 5-point scale: 0 (complete paraplegia; no lower-extremity motor function) to 4 (normal motor function).
†Tarlov 0-3.
‡Tarlov 0.
§Tarlov 1-3.
 Tarlov 0, 1, and 2.
associated with both a high incidence of comorbidity
and an increased mortality outcome.1,4 In the present
study, 79% of the control animals had paraplegia or
severe paraparesis. Therefore, our results suggest that
the ability to achieve relevant spinal cord protection
with ischemic pretreatment is limited.
In conclusion, in a rabbit model of temporary spinal
cord ischemia, ischemic pretreatment could not induce
tolerance against a moderately severe ischemic insult,
although the preconditioning stimulus clearly increased
HSP 72 levels.
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